[{"id":"kevin-harrington","kind":"person","name":"Kevin Harrington","route":"/people/kevin-harrington/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/people/europe.ts","type":"changed","fields":[{"field":"tldr","before":"\"Head and neck oncologist and oncolytic virus pioneer who led the OPTiM trial of T-VEC.\"","after":"\"Kevin Harrington is a head and neck oncologist and oncolytic virus pioneer who led the OPTiM trial of T-VEC.\""}]},{"id":"kevin-harrington","kind":"person","name":"Kevin Harrington","route":"/people/kevin-harrington/","commit":"5544163530","date":"2026-09-08","author":"Jude Gomila","message":"People: leading clinicians and scientists at European institutions","file":"src/data/people/europe.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"role"},{"field":"institutionId"},{"field":"institutions"},{"field":"specialisms"},{"field":"tldr"},{"field":"summary"},{"field":"profiles"},{"field":"cancers"},{"field":"drugs"},{"field":"technologies"},{"field":"papers"}]}]